Insiders Trades
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (22 ops.)
Latest filing published 21 Oct 2025 for Enliven Therapeutics, Inc., €228k. Read the official filing
Filing timeline
BuySaleSamuel Kintz
Insider track record
Disclosed buys
0
Disclosed sells
22
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Samuel Kintz: trading record in brief
All filings by Samuel Kintz on record concern Enliven Therapeutics, Inc. Over a trading history stretching from 25 September 2023 to 17 November 2025, the count stands at 33 filings.
On the market, this insider has only sold: 22 sales, €3.0M in total. The rest of the record consists of 11 option exercises. Since January 2025: no purchases and 14 sales on the market.
On 19 November 2025 came the latest disclosure, an open-market sale for €235k in Enliven Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Samuel Kintz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
12,500 shares@ US$21.3323Common StockSEC:0001967168-25-000007:0
3,700 shares@ US$20.06152.3% of flowCommon StockSEC:0001967168-25-000006:0
2,800 shares@ US$20.031.7% of flowCommon StockSEC:0001967168-25-000005:0
5,000 shares@ US$19.09463.1% of flowCommon StockSEC:0001967168-25-000004:0
1,517 shares@ US$20.00231.0% of flowCommon StockSEC:0001415889-25-022649:0
10,393 shares@ US$20.02377.0% of flowCommon StockSEC:0001415889-25-022459:0
4,150 shares@ US$21.57873.3% of flowCommon StockSEC:0001415889-25-020087:0
10,502 shares@ US$22.07578.9% of flowCommon StockSEC:0001415889-25-017730:0
7,500 shares@ US$20.04696.4% of flowCommon StockSEC:0001415889-25-015785:0
5,000 shares@ US$16.49063.8% of flowCommon StockSEC:0001415889-25-013992:0
5,330 shares@ US$20.07634.9% of flowCommon StockSEC:0001415889-25-012030:0
5,000 shares@ US$16.41923.7% of flowCommon StockSEC:0001415889-25-011121:0
12,500 shares@ US$20.825612.4% of flowCommon StockSEC:0001415889-25-008609:0
924 shares@ US$30.00291.3% of flowCommon StockSEC:0001415889-24-025503:0
13,167 shares@ US$27.954617.4% of flowCommon StockSEC:0001415889-24-024991:0
12,206 shares@ US$27.510415.8% of flowCommon StockSEC:0001415889-24-024901:0
526 shares@ US$27.53710.7% of flowCommon StockSEC:0001415889-24-024671:0
12,000 shares@ US$22.893212.7% of flowCommon StockSEC:0001415889-24-022512:0
2,270 shares@ US$27.55733.0% of flowCommon StockSEC:0001415889-24-020687:0
3,793 shares@ US$24.534.4% of flowCommon StockSEC:0001415889-24-020265:0
11,422 shares@ US$21.626211.9% of flowCommon StockSEC:0001415889-24-018336:0
12,000 shares@ US$1.120.6% of flowCommon StockSEC:0001415889-24-014915:0
12,000 shares@ US$1.120.6% of flowCommon StockSEC:0001415889-24-011707:0
47,709 shares@ US$1.122.6% of flowCommon StockSEC:0001415889-24-010828:0
12,000 shares@ US$1.120.6% of flowCommon StockSEC:0001415889-24-009220:0
25 of 32 declarations
